Distribution and functionality of the somatostatin receptor subtypes in acromegaly

J Endocrinol Invest. 2003;26(8 Suppl):4-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Acromegaly / drug therapy
  • Acromegaly / metabolism*
  • Acromegaly / physiopathology
  • Adenoma / drug therapy
  • Adenoma / metabolism*
  • Animals
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Human Growth Hormone / drug effects
  • Human Growth Hormone / metabolism*
  • Humans
  • Mice
  • Octreotide / therapeutic use
  • Peptides, Cyclic / therapeutic use
  • Pituitary Neoplasms / drug therapy
  • Pituitary Neoplasms / metabolism*
  • Prolactinoma / drug therapy
  • Rats
  • Receptors, Somatostatin / classification
  • Receptors, Somatostatin / metabolism*
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Peptides, Cyclic
  • Receptors, Somatostatin
  • lanreotide
  • Human Growth Hormone
  • Somatostatin
  • Octreotide